Posttranscriptional regulation of PER1 underlies the oncogenic function of IREα

Area of Science:

• Molecular Biology
• Cancer Research
• Chronobiology

Background:

• The unfolded protein response (UPR) is implicated in cancer development, but its precise mechanisms are unclear.
• The circadian clock component PER1 mRNA is identified as a novel target.
• The interplay between UPR and circadian rhythms in cancer is an emerging area of investigation.

Purpose of the Study:

• To elucidate the molecular mechanisms linking the unfolded protein response (UPR) and carcinogenesis.
• To identify novel substrates of the UPR sensor IRE1α involved in tumor development.
• To investigate the therapeutic potential of targeting the UPR-circadian clock axis in cancer.

Main Methods:

• Utilized siRNA-mediated silencing and dominant-negative strategies to inhibit IRE1α signaling.
• Quantified PER1 mRNA levels and XBP1 splicing to assess IRE1α activity.
• Correlated molecular findings with patient survival data.

Main Results:

• Identified PER1 mRNA as a direct substrate of IRE1α endoribonuclease activity, leading to its degradation in tumor cells.
• Demonstrated that inhibiting IRE1α prevents PER1 mRNA decay, reduces tumorigenesis, and enhances survival.
• Observed that reduced patient survival correlates with lower PER1 mRNA and increased XBP1 splicing, indicating higher IRE1α activity.

Conclusions:

• Described a novel mechanism where IRE1α-mediated PER1 mRNA decay promotes tumorigenesis.
• Highlighted the critical role of the interplay between UPR and circadian clock components in cancer progression.
• Suggested that targeting IRE1α activity could be a potential therapeutic strategy for cancer treatment.